Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma

Liver International

Volumn 25, Issue 6, 2005, Pages 1189-1196

  Shim, Su Jung ^a   Seong, Jinsil ^a   Han, Kwang Hyub ^b   Chon, Chae Yoon ^b   Suh, Chang Ok ^a   Lee, Jong Tae ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adriamycin; Chemoembolization; Gelform; Hepatocellular carcinoma; Radiotherapy; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DUODENITIS; DUODENUM ULCER; FEMALE; FEVER; GASTRITIS; HUMAN; HYPERBILIRUBINEMIA; HYPOALBUMINEMIA; INTERMETHOD COMPARISON; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PROGNOSIS; RADIATION DOSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH ULCER; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR VOLUME; VOMITING;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 28944444790     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01170.x     Document Type: Article

References (44)

1. Okuda S. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma. J Hepatol 1990; 11: 181-4.
2. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carciniomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1994; 33(suppl): 84-8.
3. Stefanini G F, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, et al. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma: an Italian experience. Cancer 1995; 75: 2427-34.
4. Vetter D, Wenger J J, Bergier J M, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a western comparative study in 60 patients. Hepatology 1991; 13: 427-33.
5. Bronowicki J P, Vetter D, Dumas F, Boudjema K, Bader R, Weiss A M, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 1994; 74: 16-24.
6. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68: 2150-4.
7. Lin D Y, Liaw Y F, Lee T, Lai C M. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Gastroenterol 1988; 94: 453-6.
8. Okamura J, Horikawa S, Fujiyama T, Monden M, Kambayashi J, Sikujara O, et al. An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 1982; 6: 352-7.
9. Sakurai M, Okamura J, Kuroda C. Transcatheter chemoembolization effective for treating hepatocellular carcinoma: a histopathologic study. Cancer 1984; 54: 387-92.
10. Yu Y Q, Xu D B, Zhou X D, Lu J Z, Tang Z Y, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993; 71: 62-5.
11. Bruix J, Llovet J, Castells A, Montana X, Bru C, Ayuso M C, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
12. Pelletier G, Roche A, Ink O, Anciaux M L, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatology 1990; 11: 181-4.
13. Groupe D'Etude et de Traitement du Carcinome Hepatocellulaire: a comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma [see comments]. N Engl J Med 1995; 332: 1256-61.
14. Madden M V, Krige J E, Bailey S, Beningfield S J, Geddes C, Werner I D, et al. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1993; 34: 1598-600.
15. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001; 92: 1516-24.
16. Lencioni R, Paolicchi A, Moretti M, Pinto F, Armillotta N, Di Guilio M, et al. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 1998; 8: 439-44.
17. Kirchhoff T, Chavan A, Galanski M. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1998; 10: 907-9.
18. Lawrence T S, Robertson J M, Ascher M S, Jirtle R L, Ensminger W D, Fajardo L F. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995; 31: 1237-48.
19. Cochrance A M, Murray-Lyon I M, Brinkley D M, Williams R. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer 1977; 40: 609-14.
20. Dhir V, Swaroop V S, Mohandas K M, Dinshaw K A, Desai D C, Nagral A, et al. Combination chemotherapy and radiation for palliation of hepatocellular carcinoma. Am J Clin Oncol 1992; 15: 304-7.
21. Epstein B, Ettinger D, Leichner P K, Order S E. Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma. Cancer 1991; 67: 896-900.
22. Friedman M A, Volberding P A, Cassidy M J, Redder K J, Wasserman T H, Phillips T L. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5- fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep 1979; 63: 1885-8.
23. Stillwagon G B, Order S E, Guse C G, Klein J L, Leichner P K, Leibel S A, et al. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: a Radiation Therapy Oncology Group(RTOG) study. Int J Radiat Oncol Biol Phys 1989; 17: 1223-9.
24. Cheng J C-H, Chuang V P, Cheng S H, Huang A T, Lin Y-M, Cheng T-I, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1989; 47: 435-42.
25. Lawrence T S, Tesser R J, Ten Haken R K. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 1990; 19: 1041-7.
26. Lawrence T S, Ten Haken R K, Kessler M L, Robertson J M, Lyman J T, Lavigne M L, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992; 23: 781-78.
27. Le Pechoux C L, Akine Y, Tokita N, Sumi M, Churei H, Takayasu K, et al. Case report: hepatocellular carcinoma diagnosed radiologically treated by transcatheter arterial embolization and limited-field radiotherapy. Br J Radiol 1994; 67: 591-5.
28. Yoshikawa M, Ebara M, Ohto M, Miyoshi T. A combination treatment of transcatheter arterial embolization(-TAE) and irradiation for hepatocellular carcinoma(HCC): evaluation for therapeutic efficacy in comparison with TAE or irradiation alone. Jpn J Gastroenterol 1990; 87: 225-34.
29. Mausuura M, Ishikawa A, Nakajima N, Itoh K, Matsumoto M. Radical radiation therapy of hepatocellular carcinoma. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54: 628-35.
30. Guo W J, Yu E X. Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. Br J Radiol 2000; 73: 1091-7.
31. Chia-Hsien Cheng J, Chuang V P, Cheng S H, Lin Y M, Cheng T I, Yang P S, et al. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization. Int J Cancer 2001; 96: 243-52.
32. Seong J, Park H C, Han K H, Lee D Y, Lee J T, Chon C Y, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000; 47: 1331-5.
33. Matsuura M, Nakajima N, Arai K, Ito K. The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology 1998; 45: 791-6.
34. Seong J, Park H C, Han K H, Chon C Y, Chu S S, Kim G E, et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinom: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55: 329-36.
35. Higuchi T, Kikychi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 1994; 73: 2259-63.
36. Hatanaka Y, Yamashita Y, Takahahi M, Koga Y, Saito R, Nakashima K, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195: 747-52.
37. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-23.
38. Seong J, Park H C, Han K H, Chon C Y, Chu S S, Kim G E, et al. Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. Hepatol Res 2003; 27(1): 30-5.
39. Robertson J M, Lawrence T S, Dworzanin L M, Andrews J C, Walker S, Kessler M L, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993; 11: 1286-93.
40. Order S E, Stillwagon G B, Klein J L, Leichner P K, Siegelman S S, Fishman E K, et al. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1985; 13: 1573-82.
41. Park H C, Seong J, Han K H, Chon C Y, Moon Y M, Sh C O, et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 150-5.
42. Dawson L A, Mcginn C J, Normolle D, Ten Haken R K, Walker S, Ensminger W, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210-8.
43. Seong J, Han K H, Park Y N, Nam S H, Kim S H, Keum W S, et al. Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetanide-induced liver cirrhosis. Int J Radiat Oncol Biol Phys 2003; 57: 282-8.
44. Matsumata T, Kanematsu T, Yoshid Y, Furuta T, Yanaga K, Sugimachi K. The indocyanine green test enables prediction of postoperative complication after hepatic resection. World J Surgery 1987; 11: 678-81.